Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W D Figg

Showing results (131-140 of 135) with videos related to

Pageof 14
Sort By:
You have reached the last page of results.This site can display upto 135 results.
Journal of Translational Science|March 26, 2019
First-in-human phase 0 study of <sup>111</sup>In-CHX-A"-DTPA trastuzumab for HER2 tumor imagingK A Kurdziel, E Mena, Y McKinney, et al.
United European Gastroenterology Journal|November 5, 2015
A phase II study of TRC105 in patients with hepatocellular carcinoma who have progressed on sorafenibA G Duffy, S V Ulahannan, L Cao, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 7, 2001
Concurrent paclitaxel and radiation in the treatment of locally advanced head and neck cancerJ B Sunwoo, L L Herscher, G S Kroog, et al.
International Journal of Cancer|May 20, 2016
Modulation of tumor eIF4E by antisense inhibition: A phase I/II translational clinical trial of ISIS 183750-an antisense oligonucleotide against eIF4E-in combination with irinotecan in solid tumors and irinotecan-refractory colorectal cancerA G Duffy, O V Makarova-Rusher, S V Ulahannan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 5, 1999
Eligibility and response guidelines for phase II clinical trials in androgen-independent prostate cancer: recommendations from the Prostate-Specific Antigen Working GroupG J Bubley, M Carducci, W Dahut, et al.
Pageof 14

Showing results (131-140 of 135) with videos related to

Sort By:
Pageof 14
You have reached the last page of results.This site can display upto 135 results.
Journal of Translational Science|March 26, 2019
First-in-human phase 0 study of <sup>111</sup>In-CHX-A"-DTPA trastuzumab for HER2 tumor imagingK A Kurdziel, E Mena, Y McKinney, et al.
United European Gastroenterology Journal|November 5, 2015
A phase II study of TRC105 in patients with hepatocellular carcinoma who have progressed on sorafenibA G Duffy, S V Ulahannan, L Cao, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 7, 2001
Concurrent paclitaxel and radiation in the treatment of locally advanced head and neck cancerJ B Sunwoo, L L Herscher, G S Kroog, et al.
International Journal of Cancer|May 20, 2016
Modulation of tumor eIF4E by antisense inhibition: A phase I/II translational clinical trial of ISIS 183750-an antisense oligonucleotide against eIF4E-in combination with irinotecan in solid tumors and irinotecan-refractory colorectal cancerA G Duffy, O V Makarova-Rusher, S V Ulahannan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 5, 1999
Eligibility and response guidelines for phase II clinical trials in androgen-independent prostate cancer: recommendations from the Prostate-Specific Antigen Working GroupG J Bubley, M Carducci, W Dahut, et al.
Pageof 14